3rd Circ. Parses 'Could' And 'Would' In Lipitor Lawsuit
By Carla Baranauckas · September 30, 2025, 11:02 PM EDT
A Third Circuit panel questioned Tuesday whether drug wholesalers and health plans had offered enough evidence that Pfizer Inc. and Ranbaxy Laboratories Ltd. conspired to delay generic competition for the cholesterol...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login